2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1881962256 PHARM D
Verify on CMS →

Ali Namazifard, PHARM D

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Tucson, Arizona.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 12,377 in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
317
Medicare Part D claims · 271 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 256
Generic prescribing
0%
generic claims · 100% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Ali Namazifard, PHARM D filed 317 Medicare Part D claims in 2023 as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Tucson, Arizona, prescribing 0% generic.

317
Part D claims, 2023
0%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Ali Namazifard, PHARM D's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

317 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Ali Namazifard, PHARM D?

Quality data not reported

NPI registry status

Active

Issued 12/13/2011

NPI 1881962256

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

12,377 US NPIs in this specialty

Medicare Part D claims

317 24% vs specialty avg

2023 prescription claims

Specialty avg: 256

Specialty distribution in Arizona

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among Arizona providers

Arizona providers
Pharmacist - 5.6%Pharmacist5.6%Behavior Technician - 5.6%Behavior Technician5.6%Family Nurse Practitioner - 4.3%Family Nurse Practitioner4.3%Physical Therapist - 4.2%Physical Therapist4.2%Speech-Language Pathologist - 3.5%Speech-Language Pathologist3.5%Student in an Organized Health Care Education/Training Program - 3.5%Student in an Organized Health Care Education/Training Program3.5%Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist - 0.2%Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist0.2%
Largest specialties in Arizona (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Ali Namazifard, PHARM D appears in the CMS NPPES registry as a Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider holding PHARM D credentials at 5478 W RED RACER DR, Tucson, AZ, 85742, with a listed phone of (520) 248-0240. NPI 1881962256 was issued on 12/13/2011.

Medicare Part D records for calendar year 2023 show 317 prescription claims written by this provider, covering 271 Medicare beneficiaries and totaling roughly $89K in drug spend, split 100% brand-name and 0% generic by claim count.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist is a mid-sized specialty nationwide, with 12,377 enrolled providers across 55 states and an average of 256 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5478 W RED RACER DR
Tucson, AZ 85742

Provider Details

NPI 1881962256
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials PHARM D
Gender Male
NPI Issued 12/13/2011

Brand vs generic prescribing mix · Brand-heavy

Ali Namazifard, PHARM D - brand share 100.0%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist average

100% brand-name claims vs 0% generic, on 317 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

317
Total Claims
$89K
Total Drug Cost
271
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
317
Total Day Supply
317
Brand vs Generic
100% brand / 0% generic
Brand Drug Cost
$89K
Generic Drug Cost
$0

Patient Demographics

Average Patient Age
76.2 years
Avg HCC Risk Score
0.98
Gender Split
55% female / 45% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Arexvy
Rsvpref3 Antigen/As01e/Pf
222
Shingrix
Varicella-Zoster Ge/As01b/Pf
73
Boostrix Tdap
"Diphth
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How Ali Namazifard, PHARM D fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

12,377
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
256
Avg Claims per Provider

Ali Namazifard, PHARM D's 317 claims are above the specialty average of 256.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in Arizona

Other clinicians with the same primary specialty enrolled in Arizona, drawn from the same CMS NPPES roster as Namazifard.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Arizona medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Ali Namazifard, PHARM D's specialty?
Ali Namazifard, PHARM D specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in Tucson, Arizona. Credentials: PHARM D.
How much does Ali Namazifard, PHARM D prescribe under Medicare Part D?
In 2023, Ali Namazifard, PHARM D wrote 317 Medicare Part D claims totaling $89K in drug costs for 271 beneficiaries.
Where is Ali Namazifard, PHARM D located?
Ali Namazifard, PHARM D is located at 5478 W RED RACER DR, Tucson, AZ, 85742. Phone: (520) 248-0240.
What is Ali Namazifard, PHARM D's NPI number?
Ali Namazifard, PHARM D's National Provider Identifier (NPI) is 1881962256, issued on 12/13/2011.
Does Ali Namazifard, PHARM D prescribe more brand-name or generic drugs?
Ali Namazifard, PHARM D's prescribing is 100% brand-name and 0% generic drugs by claim count, with $89K in brand drug costs.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US?
There are 12,377 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 256 Medicare Part D claims per year.
What drugs does Ali Namazifard, PHARM D prescribe most often?
Based on 2023 Medicare Part D data, Ali Namazifard, PHARM D's most frequently prescribed drugs include Arexvy, Shingrix, Boostrix Tdap. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Ali Namazifard, PHARM D accept Medicare?
Ali Namazifard, PHARM D appears in CMS Medicare data with 317 Part D claims and 271 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ali Namazifard, PHARM D's credentials?
Ali Namazifard, PHARM D's NPI is 1881962256 with credentials PHARM D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.